Covaxin may face hurdles post Brazil’s move to halt its import
Bharat Biotech International's Covaxin was refused an emergency use licence in Brazil due to suspected serious lapses at its Hyderabad plant. Other health authorities, as well as the World Health Organization, may be slow to approve the Indian-made covid vaccine, according to experts. Others hypothesised that BharatBiotech could still be able to fulfil the Brazilians' needs.
